<DOC>
	<DOC>NCT02224404</DOC>
	<brief_summary>The primary objective of this post market clinical follow-up (PMCF) investigation is to evaluate performance and safety of Exufiber when used as intended in Stage II-IV pressure ulcers (PU).</brief_summary>
	<brief_title>Post Market Clinical Follow-up Investigation to Evaluate Performance and Safety on Pressure Ulcers, PU, When Using Exufiber as Intended</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Pressure Ulcer</mesh_term>
	<criteria>1. Both gender â‰¥18 years old. 2. Subjects with Stage 2, 3 or 4 cavity pressure ulcer (acc to EPUAP) 3. Exuding pressure ulcer 4. Signed Informed Consent. 1. Known allergy/hypersensitivity to the dressing. 2. Infected wounds, (2 signs of infection/local inflammation and a positive swab) 3. Stage 1 PU 4. Dry wounds 5. Subjects who will have problems following the protocol 6. Subjects included in other ongoing clinical investigation at present or during the past 30 days</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
</DOC>